Health

Top Stories

Features & Analysis

Our Experts

Hopes for new Alzheimer's drug dashed

A major trial of a drug to treat mild dementia due to Alzheimer's disease has ended in failure. Patients on Solanezumab did not show any slowing in cognitive decline.

23 November 2016
Fergus Walsh Medical correspondent